Page 5 - Alan Lim News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KUALA LUMPUR (Feb 4): RHB Research Institute expects Supermax Corp Bhd to distribute special dividends in the form of cash or shares for the third quarter ending March 31, 2021 (3QFY21) and 4QFY21. Its analyst Alan Lim said in a note today that he emerged from an analyst briefing by the company feeling positive on its long-term prospects. According to Lim, the company’s net cash level had surged to RM3.41 billion or RM1.32 per share as at the end of December last year from RM856 million six months ago. “Additionally, it currently holds 151.9 million treasury shares, which could be utili...

KUALA LUMPUR (Jan 18): Top Glove Corp Bhd shares are trading at an unprecedented low price-to-earnings ratio (PER) of 4.9 times based on estimated earnings for the current financial year ending Aug 31, 2021 after what analysts believe was overdone selling on the stock as investors weighed the rubber glove manufacturer’s outlook against the global Covid-19 pandemic and usage of vaccines to curb the spread of the outbreak. In a note today, RHB Investment Bank Bhd's (RHB IB) Alan Lim wrote that at Top Glove’s last closing share price of RM6.42, the stock's price has declined by 33% from its...

KUALA LUMPUR (Jan 14): RHB Research has upgraded Duopharma Biotech Bhd to "buy" at RM3.39 with a higher target price (TP) of RM4 (from RM3.30) as clarity of Duopharma’s vaccine participation in Malaysia increased significantly. In a note today, RHB Research analyst Alan Lim said the TP of Duopharma was raised based on discounted cash flow (DCF)-derived valuation by one year of 40.7 times price-earnings ratio (PER) forecasted for the financial year ending Dec 31, 2022 (FY22F) (close to +3 standard deviation) as well as lowering beta assumptions due to lower share price volatility seen ...

KUALA LUMPUR (Dec 10): The environmental, social and governance (ESG) issues afflicting Top Glove Corp Bhd have led to analysts revising the company’s valuations. CGS-CIMB, while maintaining its “add” call for Top Glove, has cut its target price (TP) on the rubber glove giant by 11% to RM8.90 per share from RM10 previously. This cut is premised on a lower price-to-earnings (PE) ratio of 16 times for calendar year 2022 (CY22) from 17 times previously. “We cut our TP to RM8.90 based on 16 times CY22 P/E, -0.5SD (standard deviation) of its five-year mean (previously 17 times P/E). Th...

KUALA LUMPUR (Dec 10): Some analysts that cover Top Glove Corp Bhd have raised their earnings forecasts for the glove making giant, but kept their target prices (TPs) for the counter. The move is considered unusual, since an increase in earnings forecasts typically leads to an upward revision of TPs, or for stocks that do not have "buy" calls, an upgrade in recommendations. Kenanga Research's Raymond Choo pointed out that Top Glove's first quarter ended Nov 30, 2020 (1QFY21) profit after tax and minority interests of RM2.38 billion came in at 36% of Kenanga's full-year forecasts and 26% of th...